Gardner Donald T. III's Form 4 filing
Kewaunee Scientific Corp (KEQU) · filed Mar 28, 2025
- Accession no.
- 0001775052-25-000004
- Filed
- Mar 28, 2025
- Trade date
- Mar 26, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $120.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gardner Donald T. IIICIK 0001775052 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 26, 2025 | Common Stock | SSaleDisposed | −875 | $39.17F1 | −$34,273.75 | 20,483 | Direct | |
| Mar 26, 2025 | Common Stock | SSaleDisposed | −2,124 | $40.36F2 | −$85,724.64 | 18,359 | Direct | |
| Mar 26, 2025 | Common Stock | SSaleDisposed | −1 | $41.25 | −$41.25 | 18,358 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reflects the weighted average purchase price of the transactions reported. The price range of such transactions was $38.97 to $39.25. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
- F2
The price reflects the weighted average purchase price of the transactions reported. The price range of such transactions was $40.00 to $40.85. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.